Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic Regimens and Neuroprotection in FESS
NCT07181564Recruiting
- Sponsor
- University General Hospital of Patras
- Start
- Sep 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of ketamine and magnesium sulfate in chronic rhinosinusitis (CRS) (4 arms), sponsored by University General Hospital of Patras. Primary endpoints: Serum S100B concentration, Serum neuron-specific enolase concentration and 2 more. Started Sep 2025; status: recruiting.
02
Drugs
ketaminemagnesium sulfate
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT07181564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07181564.